| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 239,146 | 225,028 | 230,690 | 263,918 | | Cost of Revenue | 138,286 | 129,106 | 141,184 | 176,439 | | | Gross Profit | 100,860 | 95,922 | 89,506 | 87,479 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 42,781 | 39,132 | 41,486 | 57,133 | | Non Recurring | (3,920) |
-
| 3,920 |
-
| | Others | 32,049 | 30,261 | 31,143 | 112,544 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 29,950 | 26,529 | 12,957 | (82,198) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 577 | 825 | 4,205 | 3,178 | | Earnings Before Interest And Taxes | 44,707 | 42,834 | 32,260 | (69,062) | | Interest Expense | 22,736 | 21,395 | 18,809 | 19,064 | | Income Before Tax | 21,971 | 21,439 | 13,451 | (88,126) | | Income Tax Expense | 6,865 | 1,093 | 38,641 | (22,301) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 64,458 | 20,346 | (25,190) | (65,825) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 15,106 | 20,346 | (25,190) | (65,825) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $15,106 | $20,346 | ($25,190) | ($65,825) |
|
0.51% Nasdaq 
Income Statement
